List of Tables
    Table 1. Global Diabetes Drugs Sales (M Units) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Diabetes Drugs Sales (M Units) Comparison by Application (2021-2027)
    Table 3. Global Diabetes Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Diabetes Drugs Covered in This Study
    Table 5. Global Diabetes Drugs Sales (M Units) of Key Manufacturers (2016-2021)
    Table 6. Global Diabetes Drugs Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Diabetes Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Diabetes Drugs Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Diabetes Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Diabetes Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Diabetes Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Diabetes Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drugs as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Diabetes Drugs Sales by Region (2016-2021) & (M Units)
    Table 16. Global Diabetes Drugs Sales Market Share by Region (2016-2021)
    Table 17. Global Diabetes Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Diabetes Drugs Sales by Country (2016-2021) & (M Units)
    Table 19. North America Diabetes Drugs Sales Market Share by Country (2016-2021)
    Table 20. North America Diabetes Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Diabetes Drugs Revenue Market Share by Country (2016-2021)
    Table 22. Europe Diabetes Drugs Sales by Country (2016-2021) & (M Units)
    Table 23. Europe Diabetes Drugs Sales Market Share by Country (2016-2021)
    Table 24. Europe Diabetes Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Diabetes Drugs Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Diabetes Drugs Sales by Region (2016-2021) & (M Units)
    Table 27. Asia Pacific Diabetes Drugs Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Diabetes Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Diabetes Drugs Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Diabetes Drugs Sales by Country (2016-2021) & (M Units)
    Table 31. Latin America Diabetes Drugs Sales Market Share by Country (2016-2021)
    Table 32. Latin America Diabetes Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Diabetes Drugs Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Diabetes Drugs Sales by Country (2016-2021) & (M Units)
    Table 35. Middle East and Africa Diabetes Drugs Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Diabetes Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Diabetes Drugs Revenue Market Share by Country (2016-2021)
    Table 38. Global Diabetes Drugs Sales (M Units) by Type (2016-2021)
    Table 39. Global Diabetes Drugs Sales Market Share by Type (2016-2021)
    Table 40. Global Diabetes Drugs Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Diabetes Drugs Revenue Share by Type (2016-2021)
    Table 42. Global Diabetes Drugs Price (USD/Unit) by Type (2016-2021)
    Table 43. Global Diabetes Drugs Sales (M Units) by Application (2016-2021)
    Table 44. Global Diabetes Drugs Sales Market Share by Application (2016-2021)
    Table 45. Global Diabetes Drugs Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Diabetes Drugs Revenue Share by Application (2016-2021)
    Table 47. Global Diabetes Drugs Price (USD/Unit) by Application (2016-2021)
    Table 48. Sanofi Corporation Information
    Table 49. Sanofi Description and Business Overview
    Table 50. Sanofi Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 51. Sanofi Diabetes Drugs Product
    Table 52. Sanofi Recent Developments/Updates
    Table 53. AstraZeneca Corporation Information
    Table 54. AstraZeneca Description and Business Overview
    Table 55. AstraZeneca Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 56. AstraZeneca Diabetes Drugs Product
    Table 57. AstraZeneca Recent Developments/Updates
    Table 58. Bayer Corporation Information
    Table 59. Bayer Description and Business Overview
    Table 60. Bayer Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 61. Bayer Diabetes Drugs Product
    Table 62. Bayer Recent Developments/Updates
    Table 63. Biocon Corporation Information
    Table 64. Biocon Description and Business Overview
    Table 65. Biocon Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 66. Biocon Diabetes Drugs Product
    Table 67. Biocon Recent Developments/Updates
    Table 68. Boehringer Ingelheim Corporation Information
    Table 69. Boehringer Ingelheim Description and Business Overview
    Table 70. Boehringer Ingelheim Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 71. Boehringer Ingelheim Diabetes Drugs Product
    Table 72. Boehringer Ingelheim Recent Developments/Updates
    Table 73. Dongbao Pharmaceutical Corporation Information
    Table 74. Dongbao Pharmaceutical Description and Business Overview
    Table 75. Dongbao Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 76. Dongbao Pharmaceutical Diabetes Drugs Product
    Table 77. Dongbao Pharmaceutical Recent Developments/Updates
    Table 78. Eli Lilly Corporation Information
    Table 79. Eli Lilly Description and Business Overview
    Table 80. Eli Lilly Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 81. Eli Lilly Diabetes Drugs Product
    Table 82. Eli Lilly Recent Developments/Updates
    Table 83. Ganlee Corporation Information
    Table 84. Ganlee Description and Business Overview
    Table 85. Ganlee Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 86. Ganlee Diabetes Drugs Product
    Table 87. Ganlee Recent Developments/Updates
    Table 88. Ginwa Corporation Information
    Table 89. Ginwa Description and Business Overview
    Table 90. Ginwa Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 91. Ginwa Diabetes Drugs Product
    Table 92. Ginwa Recent Developments/Updates
    Table 93. Guangzhou Baiyun Mountain Corporation Information
    Table 94. Guangzhou Baiyun Mountain Description and Business Overview
    Table 95. Guangzhou Baiyun Mountain Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 96. Guangzhou Baiyun Mountain Diabetes Drugs Product
    Table 97. Guangzhou Baiyun Mountain Recent Developments/Updates
    Table 98. Hisun Pharmacy Corporation Information
    Table 99. Hisun Pharmacy Description and Business Overview
    Table 100. Hisun Pharmacy Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 101. Hisun Pharmacy Diabetes Drugs Product
    Table 102. Hisun Pharmacy Recent Developments/Updates
    Table 103. Hua Dong Corporation Information
    Table 104. Hua Dong Description and Business Overview
    Table 105. Hua Dong Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 106. Hua Dong Diabetes Drugs Product
    Table 107. Hua Dong Recent Developments/Updates
    Table 108. Huadong Medicine Corporation Information
    Table 109. Huadong Medicine Description and Business Overview
    Table 110. Huadong Medicine Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 111. Huadong Medicine Diabetes Drugs Product
    Table 112. Huadong Medicine Recent Developments/Updates
    Table 113. Jumpcan Pharmacy Corporation Information
    Table 114. Jumpcan Pharmacy Description and Business Overview
    Table 115. Jumpcan Pharmacy Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 116. Jumpcan Pharmacy Diabetes Drugs Product
    Table 117. Jumpcan Pharmacy Recent Developments/Updates
    Table 118. KELUN Corporation Information
    Table 119. KELUN Description and Business Overview
    Table 120. KELUN Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 121. KELUN Diabetes Drugs Product
    Table 122. KELUN Recent Developments/Updates
    Table 123. Merck & Co. Corporation Information
    Table 124. Merck & Co. Description and Business Overview
    Table 125. Merck & Co. Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 126. Merck & Co. Diabetes Drugs Product
    Table 127. Merck & Co. Recent Developments/Updates
    Table 128. MSD Corporation Information
    Table 129. MSD Description and Business Overview
    Table 130. MSD Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 131. MSD Diabetes Drugs Product
    Table 132. MSD Recent Developments/Updates
    Table 133. North China Pharmaceutical Group Corporation Corporation Information
    Table 134. North China Pharmaceutical Group Corporation Description and Business Overview
    Table 135. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 136. North China Pharmaceutical Group Corporation Diabetes Drugs Product
    Table 137. North China Pharmaceutical Group Corporation Recent Developments/Updates
    Table 138. Novartis Corporation Information
    Table 139. Novartis Description and Business Overview
    Table 140. Novartis Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 141. Novartis Diabetes Drugs Product
    Table 142. Novartis Recent Developments/Updates
    Table 143. Novo Nordisk Corporation Information
    Table 144. Novo Nordisk Description and Business Overview
    Table 145. Novo Nordisk Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 146. Novo Nordisk Diabetes Drugs Product
    Table 147. Novo Nordisk Recent Developments/Updates
    Table 148. Sanofi Corporation Information
    Table 149. Sanofi Description and Business Overview
    Table 150. Sanofi Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 151. Sanofi Diabetes Drugs Product
    Table 152. Sanofi Recent Developments/Updates
    Table 153. SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
    Table 154. SHIJIAZHUANG YILING PHARMACEUTICAL Description and Business Overview
    Table 155. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 156. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product
    Table 157. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Developments/Updates
    Table 158. Takeda Corporation Information
    Table 159. Takeda Description and Business Overview
    Table 160. Takeda Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 161. Takeda Diabetes Drugs Product
    Table 162. Takeda Recent Developments/Updates
    Table 163. Taloph Corporation Information
    Table 164. Taloph Description and Business Overview
    Table 165. Taloph Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 166. Taloph Diabetes Drugs Product
    Table 167. Taloph Recent Developments/Updates
    Table 168. Tianan Pharmaceutical Corporation Information
    Table 169. Tianan Pharmaceutical Description and Business Overview
    Table 170. Tianan Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 171. Tianan Pharmaceutical Diabetes Drugs Product
    Table 172. Tianan Pharmaceutical Recent Developments/Updates
    Table 173. Tonghua DongBao Corporation Information
    Table 174. Tonghua DongBao Description and Business Overview
    Table 175. Tonghua DongBao Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 176. Tonghua DongBao Diabetes Drugs Product
    Table 177. Tonghua DongBao Recent Developments/Updates
    Table 178. Wanbang Biopharmaceuticals Corporation Information
    Table 179. Wanbang Biopharmaceuticals Description and Business Overview
    Table 180. Wanbang Biopharmaceuticals Diabetes Drugs Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 181. Wanbang Biopharmaceuticals Diabetes Drugs Product
    Table 182. Wanbang Biopharmaceuticals Recent Developments/Updates
    Table 183. Production Base and Market Concentration Rate of Raw Material
    Table 184. Key Suppliers of Raw Materials
    Table 185. Diabetes Drugs Distributors List
    Table 186. Diabetes Drugs Customers List
    Table 187. Diabetes Drugs Market Trends
    Table 188. Diabetes Drugs Growth Drivers
    Table 189. Diabetes Drugs Market Challenges
    Table 190. Diabetes Drugs Market Restraints
    Table 191. Global Diabetes Drugs Sales Forecast by Type (2022-2027) & (M Units)
    Table 192. Global Diabetes Drugs Sales Market Share Forecast by Type (2022-2027)
    Table 193. Global Diabetes Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 194. Global Diabetes Drugs Revenue Market Share Forecast by Type (2022-2027)
    Table 195. Global Diabetes Drugs Sales Forecast by Application (2022-2027) & (M Units)
    Table 196. Global Diabetes Drugs Sales Market Share Forecast by Application (2022-2027)
    Table 197. Global Diabetes Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 198. Global Diabetes Drugs Revenue Market Share Forecast by Application (2022-2027)
    Table 199. Global Diabetes Drugs Sales Forecast by Region (2022-2027) & (M Units)
    Table 200. Global Diabetes Drugs Sales Market Share Forecast by Region (2022-2027)
    Table 201. Global Diabetes Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 202. Global Diabetes Drugs Revenue Market Share Forecast by Region (2022-2027)
    Table 203. Research Programs/Design for This Report
    Table 204. Key Data Information from Secondary Sources
    Table 205. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Diabetes Drugs
    Figure 2. Global Diabetes Drugs Market Share by Type in 2020 & 2027
    Figure 3. Insulin Product Picture
    Figure 4. DPP-4 Product Picture
    Figure 5. GLP-1 Product Picture
    Figure 6. SGLT-2 Product Picture
    Figure 7. Global Diabetes Drugs Market Share by Application in 2020 & 2027
    Figure 8. Type 1 Diabetes
    Figure 9. Type 2 Diabetes
    Figure 10. Global Diabetes Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Diabetes Drugs Market Size 2016-2027 (US$ Million)
    Figure 12. Global Diabetes Drugs Sales 2016-2027 (M Units)
    Figure 13. Global Diabetes Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 14. Diabetes Drugs Sales Share by Manufacturers in 2020
    Figure 15. Global Diabetes Drugs Revenue Share by Manufacturers in 2020
    Figure 16. The Global 5 and 10 Largest Diabetes Drugs Players: Market Share by Revenue in 2020
    Figure 17. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 18. Global Diabetes Drugs Sales Market Share by Region (2016-2021)
    Figure 19. Global Diabetes Drugs Sales Market Share by Region in 2020
    Figure 20. Global Diabetes Drugs Revenue Market Share by Region (2016-2021)
    Figure 21. Global Diabetes Drugs Revenue Market Share by Region in 2020
    Figure 22. U.S. Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Canada Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Germany Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. France Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. U.K. Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Italy Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Russia Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. China Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. Japan Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. South Korea Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. India Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Australia Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. China Taiwan Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Indonesia Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Thailand Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Malaysia Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. UAE Diabetes Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Diabetes Drugs by Type (2016-2021)
    Figure 45. Sales Market Share of Diabetes Drugs by Application (2016-2021)
    Figure 46. Sales Market Share of Diabetes Drugs by Application in 2020
    Figure 47. Revenue Share of Diabetes Drugs by Application (2016-2021)
    Figure 48. Revenue Share of Diabetes Drugs by Application in 2020
    Figure 49. Manufacturing Cost Structure of Diabetes Drugs
    Figure 50. Manufacturing Process Analysis of Diabetes Drugs
    Figure 51. Diabetes Drugs Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed